Led by the successful launch of the AplioTM 500 and Aplio 300 ultrasound systems, Toshiba America Medical Systems, Inc. saw a 28 percent U.S. ultrasound business growth in 2012, far exceeding the industry’s 3 percent, according to Klein Biomedical Consultants, Inc.’s industry report published in April.

Low-dose screening CT detected 132 cases of stage IA lung cancer, while chest x-ray detected 46 stage IA cancers in the first-screen results of the National Lung Screening Trial (NLST), according to research published May 23 in the New England Journal of Medicine.

While vertebroplasty provided moderate pain relief to patients suffering from osteoporotic vertebral compression fractures, the treatment offers no improvement to functional disability, according to a study published online May 21 in Radiology.

West Virginia University Hospitals (WVUH) wanted to acquire new technology to improve workflow and patient care in its busy radiology department. Using the AquilionTM ONE ViSION Edition from Toshiba America Medical Systems, Inc., WVUH has expanded its existing imaging programs for a wide range of patient cases, including brain perfusion, cardiac and orthopedic.

An automated MR workflow engine can shave minutes off exam times and reduce the likelihood of human error, according to a study published in the June issue of Academic Radiology.

I have been struggling recently with the notion that genomics is going to revolutionize our ability to diagnose and treat disease. Why? A basic tenet of information theory is simple: the more precisely you can measure something, the less information it contains.

Intraoperative lymphatic mapping provides surgeons, oncologists and referring physicians with vital information about potential malignancy in the lymphatic system, especially that of sentinel lymph nodes—usually the first check point for the diasporas of metastatic cancer cells that drain from primary tumors. Patients have a better chance of avoiding the increased morbidity associated with extensive nodal dissection by undergoing a biopsy of the sentinel lymph nodes most likely to contain metastatic disease.

As men with localized prostate cancer weigh the multitude of treatment options, they may want to consider the interplay between comorbid conditions, age and tumor features with other-cause mortality and disease-specific mortality. Older men with several comorbid conditions face a higher risk of other-cause mortality within 10 years of diagnosis, according to a study published May 20 in Annals of Internal Medicine.